Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.3048 per EA under NDC 72516001101. Its NADAC has been published 260 times since Mar 24, 2021.
DEXTROAMP-AMPHETAMIN 30 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Oryza Pharmaceuticals Inc.NDC
72516001101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210293On Market Since
10/19/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 260 times since Mar 24, 2021, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3048 per EA |
|---|---|
| All-time high | $0.4093 (Apr 14, 2021) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3373 |
| 52-week low | $0.3037 |
| Median price | $0.3135 |
| Average price | $0.3171 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 260 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.3048 per EA (NDC 72516001101), effective Jun 24, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 25.5%. It has been tracked across 260 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Mar 24, 2021, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.4093 (Apr 14, 2021), with a median of $0.3135 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHETAMIN 30 MG TAB, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 72516001101) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification